先声药业押注创新药 任晋生家族的财富能跃升吗?

投资者网
23 Feb

转型关口起起伏伏。作者丨蔡俊思维财经&投资者网 出品丨ID:touzizhebao先声药业(02096.HK,下称“公司”)仍在创新药转型的征途中。近期,公司宣布旗下企业与一家海外医药巨头签订合作。自二次上市以来,公司铆钉创新药转型,多管齐下研发、销售等方面。同时,旗下企业也对外进行融资,未来可能有资本运作的计划。对实控人任晋生而言,转型创新药是公司成长的必经之路,也是价值重塑的重要关卡。早前美股...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10